Web Results

Amprenavir - Wikipedia

en.wikipedia.org/wiki/Amprenavir

Amprenavir is a protease inhibitor used to treat HIV infection. It was approved by the Food and Drug Administration on April 15, 1999, for twice-a-day dosing ...

Amprenavir - DrugBank

www.drugbank.ca/drugs/DB00701

Accession Number, DB00701 (APRD00605). Type, Small Molecule. Groups, Approved. Description, Amprenavir is a protease inhibitor used to treat HIV infection ...

Amprenavir: Indications, Side Effects, Warnings - Drugs.com

www.drugs.com/cdi/amprenavir.html

Easy to read patient leaflet for amprenavir. Includes indications, proper use, special instructions, precautions, and possible side effects.

Agenerase Capsules (Amprenavir Capsules): Side Effects ... - RxList

www.rxlist.com/agenerase-drug.htm

Learn about Agenerase Capsules (Amprenavir Capsules) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and ...

Label - FDA

www.accessdata.fda.gov/drugsatfda_docs/label/2004/21007slr016,21039slr016_agenerase_lbl.pdf

Amprenavir is a white to cream-colored solid with a solubility of approximately 0.04 mg/mL in water at 25°C. AGENERASE Capsules are available for oral ...

Amprenavir (Agenerase)

hivinsite.ucsf.edu/InSite?page=ar-03-05

Jan 25, 2001 ... Approval. Amprenavir was approved by the U.S. Food and Drug Administration ( FDA) in 1999 for use in adults and children with HIV infection.

Agenerase (amprenavir) - CenterWatch

www.centerwatch.com/drug-information/fda-approved-drugs/drug/526/agenerase-amprenavir

Agenerase (amprenavir): For the treatment of HIV-1 infection.. New approved drug details including side effects, uses and general information.

Agenerase (Amprenavir) Capsules and Oral Solution ... - Amazon S3

s3-us-west-2.amazonaws.com/drugbank/fda_labels/DB00701.pdf?1265922806

AGENERASE (amprenavir) in combination with other antiretroviral agents is indicated for ... contains 15 mg of amprenavir in solution and the inactive ingredients ...

Amprenavir - OurMed

ourmed.org/wiki/Amprenavir

Amprenavir is an antiretroviral drug used to treat HIV/AIDS. It is branded under the tradename Agenerase. Glaxo began marketing Agenerase in April 1999.

RCSB PDB - 1T7J: crystal structure of inhibitor amprenavir in ...

www.rcsb.org/pdb/explore.do?structureId=1t7j

crystal structure of inhibitor amprenavir in complex with a multi-drug resistant variant of HIV-1 protease (L63P/V82T/I84V). DOI: 10.2210/pdb1t7j/pdb.

More Info

amprenavir, Agenerase: Drug Facts, Side Effects and Dosing

www.medicinenet.com

Amprenavir (Agenerase - discontinued brand) is a drug prescribed to treat infections with HIV. Side effects, drug interactions, and pregnancy safety information is ...

amprenavir | C25H35N3O6S - PubChem

pubchem.ncbi.nlm.nih.gov

Amprenavir is a Protease Inhibitor. The mechanism of action of amprenavir is as a HIV Protease Inhibitor, and Cytochrome P450 3A4 Inhibitor, and Cytochrome ...

Common Side Effects of Agenerase Capsules (Amprenavir ... - RxList

www.rxlist.com

Dec 19, 2015 ... Find a comprehensive guide to possible side effects including common and rare side effects when taking Agenerase Capsules (Amprenavir ...